Cytokinetics headquarters
WebJul 27, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential … WebWho is Cytokinetics. Headquarters. 350 Oyster Point Blvd, South San Francisco, California, 94080, United States. Phone Number. (650) 624-3000. Website. …
Cytokinetics headquarters
Did you know?
WebApr 3, 2024 · Cytokinetics is now down to its last late-stage candidate, aficamten, a small molecule myosin inhibitor being studied for hypertrophic cardiomyopathy (HCM). … WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing potential treatments for debilitating diseases in which …
WebCytokinetics Mission & Values We are developing potential medicines to improve the healthspan of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function. Cytokinetics Mission, Vision & Values Cytokinetics Competitors Cytokinetics competitors include BioScrip, STERIS, Perrigo, and Hikma Pharmaceuticals. WebCytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential …
WebMar 31, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Our Vision Leadership Team Cytokinetics is a late-stage biopharmaceutical company focused on … Cytokinetics is proud to have received the following recognitions for our workplace … Cytokinetics, Inc. does not by its reference above or distribution imply its … Cytokinetics is a late-stage biopharmaceutical company focused on … SEQUOIA-HCM (Safety, Efficacy, and Quantitative Understanding of … At Cytokinetics, we provide more than a job, we provide an opportunity to contribute … The key to muscle function is contraction. The principal functionality of muscle is … WebDec 14, 2024 · The FDA accepted Cytokinetics’ application in February this year based on results from late-stage clinical testing of the drug. The advisory committee voted 8 to 3 that the benefits of the drug did not outweigh its risks. While the FDA is not required to follow recommendations from advisors, it often does. The research and development journey ...
WebMar 31, 2024 · Cytokinetics Muscle Biology Therapies Home empowering muscle empowering lives Cytokinetics is committed to our mission of developing potential medicines that may improve the …
Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. orcus whiteWebEuropean Headquarters +44 (0) 20 8037.2308; 1st Floor Saffron House; 6-10 Kirby Street; London EC1N 8TS; United Kingdom; Asia-Pacific Headquarters. 80 Raffles Place #41 … orcus501WebCytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. orcus904WebFeb 17, 2024 · For the three months ended September 30, 2024, Cytokinetics reported a net loss of $142.3 million, or $1.52 per share, compared to a net loss of $76.1 million, or $0.95 per share, for the same ... orcus white punchWeb12 hours ago · Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 3 Best Stocks to Buy Now, 4/3/2024, According to Top Analysts Cytokinetics … iran currency to pakistanWebCytokinetics headquarters are located in 350 Oyster Point Blvd, South San Francisco, California, 94080, United States What are Cytokinetics’s primary industries? Cytokinetics’s main industries are: Pharmaceuticals, Manufacturing orcus\u0027 wandWebApr 11, 2024 · To Be Held May 10, 2024 To the Stockholders: NOTICE IS HEREBY GIVEN that the Annual Meeting of Stockholders of Cytokinetics, Incorporated, a Delaware corporation (the "Company"), will be held on Wednesday, May 10, 2024, at 10:00 a.m. local time at our headquarters, 350 Oyster Point Blvd., South San Francisco, CA 94080, for … iran currency to rand